Journal of Cancer Therapy
Vol.9 No.12(2018), Paper ID 89196, 13
pages
DOI:10.4236/jct.2018.912082
Treatment Outcome of Pharmacokinetics-Based Dosing of Docetaxel and Fluorouracil in Advanced Head and Neck Cancer Patients
Abdelhamid M. Fouad, Magdy M. Saber, Yahia M. Ismail, Yasser A. Sallam, Tarek M. Shouman, Reham A. A. Elshimy, Ahmed Abo Gabal
Department of Medical Oncology, National Cancer Institute, Cairo University, Cairo, Egypt
Department of Medical Oncology, National Cancer Institute, Cairo University, Cairo, Egypt
Department of Medical Oncology, National Cancer Institute, Cairo University, Cairo, Egypt
Department of Medical Oncology, National Cancer Institute, Cairo University, Cairo, Egypt
Department of Radiation Oncology, National Cancer Institute, Cairo University, Cairo, Egypt
Department of Clinical and Chemical Pathology, National Cancer Institute, Cairo University, Cairo, Egypt
Department of Radiation Oncology, National Cancer Institute, Cairo University, Cairo, Egypt
Copyright © 2018 Abdelhamid M. Fouad, Magdy M. Saber, Yahia M. Ismail, Yasser A. Sallam, Tarek M. Shouman, Reham A. A. Elshimy, Ahmed Abo Gabal et al. This is
an open access article distributed under the Creative Commons Attribution
License, which permits unrestricted use, distribution, and reproduction in any
medium, provided the original work is properly cited.
How to Cite this Article
Fouad, A. , Saber, M. , Ismail, Y. , Sallam, Y. , Shouman, T. , Elshimy, R. and Gabal, A. (2018) Treatment Outcome of Pharmacokinetics-Based Dosing of Docetaxel and Fluorouracil in Advanced Head and Neck Cancer Patients.
Journal of Cancer Therapy,
9, 998-1010. doi:
10.4236/jct.2018.912082.